Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Puma Neratinib Research Grant Opportunity: submit by Monday, April 19, 2021
Study Proposal Submission-NCCN iEnvision
NCCN AstraZeneca NSCLC Research Opportunity: submit LOIs by Monday, May 3, 2021
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

NCCN Oncology Research Program Logo

NCCN Oncology Research Program (ORP)

NCCN ORP Mission Statement

The NCCN ORP fosters innovation and knowledge discovery that improve the lives of patients with cancer.

Guiding Principles:

  1. Study both FDA-approved and investigational agents/devices, to seek novel enhanced, effective, and efficient cancer therapy.
  2. Develop new insights into cancer care delivery outcomes and quality, as well as identify solutions to barriers affecting optimal cancer management.
  3. Increase opportunities for NCCN Member Institution faculty to participate in oncologic investigation and support those who are, or will become, leaders in cancer research.
  4. Demonstrate that constructive, appropriate, and transparent collaboration between academia and industry results in valuable knowledge and improved cancer management.
  5. Ensure the dissemination of knowledge gained through the program to the medical community at large through presentations at meetings and/or publication in peer-reviewed journals.

Current Opportunities

NCCN Puma Neratinib Research Grant Opportunity: submit by Monday, April 19, 2021

NCCN AstraZeneca NSCLC Research Opportunity: submit LOIs by Monday, May 3, 2021

The NCCN Oncology Research Program (ORP) is organized to obtain funding to support scientifically meritorious research studies (clinical trials) at NCCN Member Institutions. Policies and standards for the program are set by the NCCN Investigator Steering Committee, comprised of senior research physicians appointed by each NCCN Member Institution. The NCCN ORP has received millions of dollars in research grants from major pharmaceutical companies to support investigator-initiated trials, which explore new venues of clinical investigation that answer important research questions. Studies evaluate innovative combinations and sequencing regimens of drugs, mechanisms of action of specific agents, drug resistance, or are directed toward exploring extended

View the NCCN ORP Press Releases
View the NCCN ORP Scientific Publications
View the NCCN Investigator Steering Committee
View the NCCN ORP Testimonials
View the NCCN ORP Disclosure Policy

Leading clinicians and investigators from NCCN Member Institutions evaluate promising new chemical entities or biological agents.

Members Only Section

NCCN Oncology Research Program (ORP) – Click here if you are a clinician at an NCCN Member Institution and would like to:

  • View current opportunities for research grants
  • View information regarding previously funded research grants

Industry Section

View information for the NCCN Oncology Research Program for Industry.